CPHI Frankfurt 2025 Reveals Pharma Awards Finalists Highlighting Industry Innovation and Sustainability
核心洞察
The CPHI Pharma Awards 2025 finalists have been announced across 14 categories, showcasing advances in synthetic biology, AI-enabled formulation, sustainable packaging, and patient access initiatives.
Notable innovations include Lonza's Design2Optimize platform, Evonik's world-first functional ready-to-fill capsule for ileo-colonic drug delivery, and Celtic Renewables (搜索)' green chemical transformation technology.
Winners will be announced on October 28, 2025, at the opening ceremony of CPHI Frankfurt, highlighting technologies that may influence manufacturing scalability and clinical development strategies.
The pharmaceutical industry's most significant innovations and leadership achievements have been recognized in the CPHI Pharma Awards 2025 finalist announcements, with 14 categories highlighting advances that reflect the evolving priorities of bio/pharmaceutical science and technology. The finalists represent progress in areas such as synthetic biology, artificial intelligence in formulation, patient access, and sustainable packaging.
"Across every category, the finalists are setting new standards in pharmaceutical innovation, sustainability, and patient impact," said Tara Dougal, CPHI event director at Informa Markets. "The CPHI Pharma Awards are a vital platform to spotlight the progress shaping the future of our industry."
Breakthrough Technologies in API Development
The API Development and Innovation category showcases cutting-edge approaches to drug substance manufacturing. Lonza's Design2Optimize platform leads the field alongside CMAC's scalable platform for API agglomeration titled "From Crystallization to Tablet." Merck KgaA's mPredict Co-crystal Prediction Service represents advances in computational drug design, while CordenPharma International (搜索)'s TAG Assisted Peptide Synthesis (TAPS) offers new approaches to peptide manufacturing.
Revolutionary Drug Delivery Systems
Innovation in drug delivery spans multiple categories, with Evonik Industries (搜索) nominated for EUDRACAP colon, described as the world's first functional ready-to-fill capsule for oral drug delivery targeting the ileo-colonic region. SHL Medical (搜索)'s Maggie Mix dual-chamber autoinjector features Needle Isolation Technology, while LTS Lohmann Therapie-Systeme achieved a milestone by launching the first biosimilar in an on-body injector.
Zerion Pharma's Dispersome technology and CrystecPharma's modified supercritical anti-solvent particle engineering for biomolecule stabilization represent advances in formulation science. Ypsomed (搜索)'s self-injection devices unite sustainability with patient convenience, reflecting the industry's dual focus on environmental responsibility and user experience.
Sustainability Takes Center Stage
The sustainability category demonstrates the industry's commitment to environmental stewardship. Celtic Renewables (搜索) leads the green chemical revolution by transforming industrial by-products into high-value green chemicals. AustinPx (搜索)'s KinetiSol technology offers a solvent-free, fusion-based approach that transforms poorly soluble drugs into high-bioavailability formulations.
Avantor's J.T.Baker Viral Inactivation Solution provides an environmentally safer detergent for virus removal in bioprocessing, while Kindeva advances next-generation propellants with commercial-ready capabilities in HFA152a and HFO1234ze propellants. Botanical Solution Inc. focuses on sustainable production of QS-21, the gold standard vaccine adjuvant.
Manufacturing Excellence and Digital Integration
Manufacturing innovation features prominently with Enzene's EnzeneX fully connected continuous manufacturing platform and Bausch+Ströbel's GENEX robotic, modular aseptic fill-finish platform. Coriolis Pharma Research advances lyophilization modeling, while VectorBuilder's gene drug manufacturing platform addresses the growing gene therapy market.
AI-enabled formulation tools are streamlining design and reducing experimental timelines, while circular packaging and sustainable processes point to an industry adapting its manufacturing models to meet both regulatory expectations and environmental goals.
Accelerating Innovation in Oncology and Rare Diseases
The Accelerating Innovation category highlights therapeutic advances including Accord Healthcare's Orgovyx for transforming prostate cancer care and Prestige Biopharma (搜索)'s Ullenistamab (搜索), a targeted monoclonal antibody for pancreatic cancer. NunaBio's custom, cell-free synthetic DNA technology and TriLink Biotechnologies' GMP-Grade CleanCap M6 analog represent advances in nucleic acid therapeutics.
Leadership Recognition
Individual recognition spans multiple categories, with CEO of the Year nominees including Bobby Sheng from Bora Pharmaceuticals, Lars Petersen from FUJIFILM Diosynth Biotechnologies, and Lisa Soyeon Park from Prestige Biopharma (搜索). The Woman of the Year category recognizes leaders including Adriana Kiedzierska-Mencfeld from Polpharma Biologics and Christiane Bardroff from Rentschler Biopharma.
Supply Chain and Digital Transformation
Supply chain excellence nominees include Cryoport Systems' integrated end-to-end platform and Occam Systems' AI-supercharged resilient chemical supply chains. TraceLink's Orchestration Platform for Universal Solutions (OPUS) represents advances in supply chain digitalization and transparency.
The winners will be announced on October 28 at the opening ceremony of CPHI Frankfurt 2025, which runs from October 28-30, 2025. These awards serve as a barometer of the technologies and practices most likely to influence the industry's next phase, emphasizing not only product innovation but also leadership within the sector.